These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 1841525)

  • 1. [A comparative study of the central H-cholinergic-blocking and NMDA-blocking actions of MK-801, memantin, amantadine, pyrilen and IEM-1754 in experiments on intact rats].
    Gmiro VE; Serdiuk SE
    Eksp Klin Farmakol; 2000; 63(2):16-20. PubMed ID: 10834088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of dopa decarboxylase activity in striatum of healthy human brain secondary to NMDA receptor antagonism with a low dose of amantadine.
    Deep P; Dagher A; Sadikot A; Gjedde A; Cumming P
    Synapse; 1999 Dec; 34(4):313-8. PubMed ID: 10529725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of N-methyl-D-aspartate-induced currents by the nootropic drug nefiracetam in rat cortical neurons.
    Moriguchi S; Marszalec W; Zhao X; Yeh JZ; Narahashi T
    J Pharmacol Exp Ther; 2003 Oct; 307(1):160-7. PubMed ID: 12805478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Action mechanism of adamantamines: do their activity on glutamatergic receptors intervene in the expression of their pharmacological profile?].
    Vamvakidès A
    Ann Pharm Fr; 1991; 49(5):249-57. PubMed ID: 1841525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Are there glutamatergic, anti-GABAergic or antiglycinergic components in the action mechanism of adamantamines? Study of convulsions induced by amantadine or 1-adamantylcyclopentanamine in mice].
    Vamvakides A
    Ann Pharm Fr; 1990; 48(6):312-20. PubMed ID: 2131763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamatergic neurotransmission modulation and the mechanisms of antipsychotic atypicality.
    Heresco-Levy U
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1113-23. PubMed ID: 14642971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New therapeutic possibilities with low-affinity NMDA receptor antagonists].
    Kornhuber J; Weller M
    Nervenarzt; 1996 Jan; 67(1):77-82. PubMed ID: 8676993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of excitatory amino acids in neuropathology].
    Wikinski SI; Acosta GB
    Medicina (B Aires); 1995; 55(4):355-65. PubMed ID: 8728878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Working hypothesis for the effect of GABAergic, glycinergic or glutamatergic drugs in the treatment of Parkinson disease].
    Vamvakidès A
    Ann Pharm Fr; 1990; 48(2):70-80. PubMed ID: 2291602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
    Javitt DC
    Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.